The Manufacturers Life Insurance Company Sells 5,609 Shares of HCA Healthcare, Inc. (NYSE:HCA)

The Manufacturers Life Insurance Company lowered its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 148,744 shares of the company’s stock after selling 5,609 shares during the period. The Manufacturers Life Insurance Company’s holdings in HCA Healthcare were worth $60,454,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Private Trust Co. NA boosted its position in shares of HCA Healthcare by 16.4% during the 3rd quarter. Private Trust Co. NA now owns 1,137 shares of the company’s stock worth $462,000 after acquiring an additional 160 shares in the last quarter. Hancock Whitney Corp increased its stake in shares of HCA Healthcare by 5.2% in the 3rd quarter. Hancock Whitney Corp now owns 4,111 shares of the company’s stock valued at $1,671,000 after purchasing an additional 205 shares during the last quarter. Independent Advisor Alliance lifted its position in shares of HCA Healthcare by 20.5% during the 3rd quarter. Independent Advisor Alliance now owns 1,142 shares of the company’s stock worth $464,000 after buying an additional 194 shares during the last quarter. Harvest Fund Management Co. Ltd grew its position in HCA Healthcare by 3.1% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,778 shares of the company’s stock valued at $723,000 after acquiring an additional 53 shares during the last quarter. Finally, Hartford Funds Management Co LLC boosted its stake in shares of HCA Healthcare by 1.6% in the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after purchasing an additional 39 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Stock Down 1.1 %

HCA stock opened at $325.35 on Thursday. The company has a market cap of $82.41 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. The stock’s 50 day simple moving average is $374.98 and its 200 day simple moving average is $358.51. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $245.84 and a fifty-two week high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Analyst Ratings Changes

A number of brokerages have weighed in on HCA. Barclays cut their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Oppenheimer upped their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Morgan Stanley began coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.